Please select the eligibility criteria that correspond to the clinical trial below.
Title: Feasibility Study on the Impact of Economic Incentives for Weight Loss to Improve the Management of Type 2 Diabetes Mellitus: REDEEM Feasibility Study
Brief Summary: This feasibility study aims to compare the implementation process of three different interventions that use economic incentives to promote lifestyle behavioral changes in patients with type 2 diabetes mellitus, and to identify barriers and facilitators linked to the process of implementing each of the interventions. The interventions are based on economic incentives directed to the patient (individual incentives) or a team comprised by the patient and a partner (mixed incentives).

Design: Three-month randomized control feasibility study to test the feasibility of implementing three types of intervention with economic incentives in patients with diabetes mellitus.

Setting: Diabetes outpatient clinics from a public hospital in Peru.


Options:
A: Inclusion Criteria:

* Subjects will be those patients with diabetes who speak English and/or Spanish and reside in the South Bronx.
* Subjects will be adults, \> 18 years, with diabetes, who become part of the NYC registry by virtue of having a reported HbA1c \>7% to the DOHMH.
* The sampling frame for this study comprises virtually all adults with diabetes in the South Bronx.

Exclusion Criteria:

* Age \< 18 years
* A1c \< = 7 %
* Refuses informed consent and HIPAA consent
* Cognitive dysfunction as assessed by telephone
* Does not read or speak English or Spanish
* No diabetes
B: Inclusion Criteria:

* Adult patients, 35-75 years of age
* Non-insulin treated type 2 diabetes for 1-10 years before enrollment
* Treatment with diet and oral hypoglycemic agents, or with diet only
* HbAlc of 7.0-9.0%

Exclusion Criteria:

* Type 1 diabetes
* Insulin treatment (for \&gt;7 consecutive days)
* Previous intensive SMBG management (the execution of SMBG measurements used to modify lifestyle, diet or physical activity in a systemic/structured manner and/or to manage therapeutic approach)
* impending complications of diabetes;
* serious diseases, including cardiovascular damage or limited life expectancy;
* pregnancy
C: Inclusion Criteria:

* The intervention-study comprises 40 general practices were:

  1. more than 50% of the patients with type 2 diabetes, who had participated in diabetes-consultations during the last year from the invitation-date to the project, were seen by a nurse at least once, stated by the practice. The diabetes-consultation should not only include examinations (blood tests and blood pressure measurement), but should also include communication about living with type 2 diabetes ;
  2. enrollment in the project before registration deadline (three weeks after invitation).

Patients with diabetes, alive and affiliated the practices by May 2011, were identified in a a validated diabetes database based on health registers; The national Patient Registry, The national Health Insurance Service registry, the prescription database and the laboratory database in the county.
D: Inclusion criteria for participants:

* Type 2 diabetes mellitus
* Body mass index 25-39.9 kg/m2, irrespective of HbA1c status
* Able to give consent

Exclusion Criteria for participants:

* Diagnosis of cancer or another serious comorbidity
* Pharmacotherapy for weight loss or corticosteroids
* Pregnant women
* Blindness, amputation, foot ulcer or being on dialysis
* Be companion/team support for another participant in the trial

Inclusion criteria for the companion/team support:

* Available and committed to supporting the participant in achieving their goals
* Able to provide consent

Exclusion criteria for the companion/team support:

* Physical or mental condition that does not allow him to help the participant to achieve goals

Answer: D